Terms: = Head and neck cancer AND ROS1, ROS, 6098, ENSG00000047936, P08922, MCF3, RP1-179P9_1
100920 results:
1. Thyroid Malignancy in Patients Who Underwent Thyroidectomy for Multinodular Goiter and Solitary Thyroid Nodule.
Gedamu D; Shimels T; Kassie D; Chanyalew Z; Eyasu M
JCO Glob Oncol; 2024 May; 10():e2300322. PubMed ID: 38815179
[TBL] [Abstract] [Full Text] [Related]
2. Clinimetric Properties of the Chinese Short Form of the Sarcopenia Quality of Life Questionnaire in Patients With cancer.
Liu H; Wang H; Dong M; Wang J; Wang Z; Su N; Shao D; Cui N; Cao F
J Nurs Res; 2024 Jun; 32(3):e327. PubMed ID: 38814994
[TBL] [Abstract] [Full Text] [Related]
3. [Study on mechanism of inhibiting proliferation of head and neck cancer cells by citral, active ingredient of lemon essential oil].
Chen L; Zhang YJ; Qin HW; Hu WJ; Liu YJ; Xiao GS; DU HH; Yang DL
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2364-2375. PubMed ID: 38812137
[TBL] [Abstract] [Full Text] [Related]
4. Lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck.
Fang Q; Yuan J; Zhang X; Dai L; Luo R
BMC Cancer; 2024 May; 24(1):656. PubMed ID: 38811899
[TBL] [Abstract] [Full Text] [Related]
5. The enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of oral squamous cell carcinoma.
Cheng A; Xu Q; Li B; Zhang L; Wang H; Liu C; Han Z; Feng Z
Cell Death Dis; 2024 May; 15(5):376. PubMed ID: 38811531
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Ability of Expression of Myofibroblasts in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shete MV; Shete AV; Buva K; Channe PP; Sapkal R; Nerkar Rajbhoj A
Asian Pac J Cancer Prev; 2024 May; 25(5):1477-1486. PubMed ID: 38809619
[TBL] [Abstract] [Full Text] [Related]
7. Influence of maximum diameter on fine-needle aspiration biopsy outcomes in ACR TI-RADS 5 thyroid nodules.
Cao SL; Shi WY; Niu YR; Zhao ZL; Wei Y; Wu J; Peng LL; Li Y; Yu MA
Front Endocrinol (Lausanne); 2024; 15():1374888. PubMed ID: 38808118
[TBL] [Abstract] [Full Text] [Related]
8. Meta-analyses of the relationship between five CXCL8 gene polymorphisms and overall cancer risk, and a case-control study of oral cancer.
Peng J; Wang Y; Kuang D; Wang Y; Wu G; Li H; Li D; Cao H
BMC Oral Health; 2024 May; 24(1):622. PubMed ID: 38807156
[TBL] [Abstract] [Full Text] [Related]
9. Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma.
Chen P; Fu C; Shen L; Fei Z; Luo M; Chen Y; Li H
BMC Health Serv Res; 2024 May; 24(1):676. PubMed ID: 38807104
[TBL] [Abstract] [Full Text] [Related]
10. Cellular mechanisms mediating the anti-cancer effects of carnosol on gingiva carcinoma.
Gassib N; Issa H; Loubaki L; Behaz S; Almutairi MH; Rouabhia M; Semlali A
Sci Rep; 2024 May; 14(1):12266. PubMed ID: 38806527
[TBL] [Abstract] [Full Text] [Related]
11. Donafenib as neoadjuvant therapy in locally advanced thyroid cancer: protocol for the DONATHYCA phase II prospective single-arm trial in China.
Yu J; Liu H; Wu Y
BMJ Open; 2024 May; 14(5):e081090. PubMed ID: 38806431
[TBL] [Abstract] [Full Text] [Related]
12. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
Qiu MZ; Oh DY; Kato K; Arkenau T; Tabernero J; Correa MC; Zimina AV; Bai Y; Shi J; Lee KW; Wang J; Poddubskaya E; Pan H; Rha SY; Zhang R; Hirano H; Spigel D; Yamaguchi K; Chao Y; Wyrwicz L; Disel U; Cid RP; Fornaro L; Evesque L; Wang H; Xu Y; Li J; Sheng T; Yang S; Li L; Moehler M; Xu RH;
BMJ; 2024 May; 385():e078876. PubMed ID: 38806195
[TBL] [Abstract] [Full Text] [Related]
13. [Our experience in the treatment of congenital nasal median heterotopias in children and an overview of various treatment tactics].
Molodtsova EV; Yunusov AS; Daikhes NA; Polyakov DP; Korobkin AS; Larina OM
Vestn Otorinolaringol; 2024; 89(2):28-32. PubMed ID: 38805460
[TBL] [Abstract] [Full Text] [Related]
14. LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1.
Liu D; Wang W; Wu Y; Qiu Y; Zhang L
Curr Cancer Drug Targets; 2024; 24(5):519-533. PubMed ID: 38804344
[TBL] [Abstract] [Full Text] [Related]
15. No Change in Complications Following Thyroidectomy Despite Increase in Thyroid cancer Surgeries: A Meta-Regression Analysis.
Lee JS; Lee JS; Yun HJ; Kim SM; Chang H; Lee YS; Yang J; Lee HS; Chang HS
Yonsei Med J; 2024 Jun; 65(6):348-355. PubMed ID: 38804029
[TBL] [Abstract] [Full Text] [Related]
16. Long-Term Changes of Urinary Exosomal Peptide Levels After Thyroidectomy in Patients with Thyroid cancer: A
Wang CY; Shih SR; Chen KY; Chung YC; Huang PJ
Int J Nanomedicine; 2024; 19():4667-4677. PubMed ID: 38803995
[TBL] [Abstract] [Full Text] [Related]
17. Two sisters diagnosed with familial paraganglioma syndrome type 1 (FPGL1) and multiple endocrine neoplasia type 2A (MEN2A).
Stawarz K; Durzynska M; Galazka A; Paszkowska M; Bienkowska-Pluta K; Zwolinski J; Tysarowski A; Kwiatkowska E; Podgorska A
World J Surg Oncol; 2024 May; 22(1):139. PubMed ID: 38802890
[TBL] [Abstract] [Full Text] [Related]
18. Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.
Mou Y; Liang P; Cheng X; He X; Zhang J; Liu L; Liu Q
BMC Cancer; 2024 May; 24(1):646. PubMed ID: 38802765
[TBL] [Abstract] [Full Text] [Related]
19. Expression of Glutathione Peroxidase4 in Patients with Esophageal Squamous Carcinoma and Its Impact on the Radiosensitivity of Esophageal Squamous Carcinoma.
Chen C; Gu W; Shao Y; Zheng P; Jiang J
Ann Clin Lab Sci; 2024 Mar; 54(2):160-169. PubMed ID: 38802161
[TBL] [Abstract] [Full Text] [Related]
20. Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries.
Vitale A; Caggiano V; Tufan A; Ragab G; Batu ED; Portincasa P; Aragona E; Sota J; Conti G; De Paulis A; Rigante D; Olivieri AN; Şahin A; La Torre F; Lopalco G; Cattalini M; Maggio MC; Insalaco A; Sfikakis PP; Verrecchia E; Yildirim D; Kucuk H; Kardas RC; Laymouna AH; Ghanema M; Saad MA; Sener S; Ercan Emreol H; Ozen S; Jaber N; Khalil M; Di Ciaula A; Gaggiano C; Malizia G; Affronti A; Patroniti S; Romeo M; Sbalchiero J; Della Casa F; Mormile I; Silvaroli S; Gicchino MF; Çelik NÇ; Tarsia M; Karamanakos A; Hernández-Rodríguez J; Parronchi P; Opris-Belinski D; Barone P; Recke A; Costi S; Sfriso P; Giardini HAM; Gentileschi S; Wiesik-Szewczyk E; Vasi I; Loconte R; Jahnz-Różyk K; Martín-Nares E; Torres-Ruiz J; Cauli A; Conforti A; Emmi G; Li Gobbi F; Biasi GR; Terribili R; Ruscitti P; Del Giudice E; Tharwat S; Brucato AL; Ogunjimi B; Hinojosa-Azaola A; Balistreri A; Fabiani C; Frediani B; Cantarini L
Front Immunol; 2024; 15():1397890. PubMed ID: 38799474
[TBL] [Abstract] [Full Text] [Related]
[Next]
